Effectiveness of Real-Time Quantitative PCR Compare to Repeat PCR for the Diagnosis of Charcot-Marie-Tooth Type 1A and Hereditary Neuropathy with Liability to Pressure Palsies.
10.3349/ymj.2005.46.3.347
- Author:
Jong Rak CHOI
1
;
Woon Hyoung LEE
;
Il Nam SUNWOO
;
Eun Kyung LEE
;
Chang Hoon LEE
;
Jong Baeck LIM
Author Information
1. Department of Laboratory Medicine, Yonsei University College of Medicine, Seoul, Korea. jlim@yumc.yonsei.ac.kr
- Publication Type:Original Article ; Clinical Trial ; Comparative Study ; Controlled Clinical Trial
- Keywords:
Charcot-Marie-Tooth type 1A;
HNPP;
peripheral myelin protein 22 gene;
real-time quantitative PCR
- MeSH:
Charcot-Marie-Tooth Disease/*diagnosis/*genetics;
Comparative Study;
Gene Dosage;
Genetic Screening/methods;
Hereditary Motor and Sensory Neuropathies/*diagnosis/*genetics;
Humans;
Polymerase Chain Reaction/*methods
- From:Yonsei Medical Journal
2005;46(3):347-352
- CountryRepublic of Korea
- Language:English
-
Abstract:
The majority of cases of Charcot-Marie-Tooth type 1A (CMT1A) and of hereditary neuropathy with a liability to pressure palsies (HNPP) are the result of heterozygosity for the duplication or deletion of peripheral myelin protein 22 gene (PMP22) on 17p11.2. Southern blots, pulsed-field gel electrophoresis (PFGE), fluorescence in situ hybridization (FISH) and polymorphic marker analysis are currently used diagnostic methods. But they are time-consuming, labor-intensive and have some significant limitations. We describe a rapid real- time quantitative PCR method for determining gene copy number for the identification of DNA duplication or deletion occurring in CMT1A or HNPP and compare the results obtained with REP-PCR. Six patients with CMT1A and 14 patients with HNPP [confirmed by Repeat (REP) -PCR], and 16 patients with suspicious CMT1A and 13 patients with suspicious HNPP [negative REP-PCR], and 15 normal controls were studied. We performed REP-PCR, which amplified a 3.6 Kb region (including a 1.7Kb recombination hotspot), using specific CMT1A-REP and real-time quantitative PCR on the LightCycler system. Using a comparative threshold cycle (Ct) method and beta-globin as a reference gene, the gene copy number of the PMP22 gene was quantified. The PMP22 duplication ratio ranged from 1.35 to 1.74, and the PMP22 deletion ratio from 0.41 to 0.53. The PMP22 ratio in normal controls ranged from 0.81 to 1.12. All 6 patients with CMT1A and 14 patients with HNPP confirmed by REP-PCR were positive by real-time quantitative PCR. Among the 16 suspicious CMT1A and 13 suspicious HNPP with negative REP-PCR, 2 and 4 samples, respectively, were positive by real-time quantitative PCR. Real-time quantitative PCR is a more sensitive and more accurate method than REP-PCR for the detection of PMP22 duplications or deletions, and it is also faster and easier than currently available methods. Therefore, we believe that the real-time quantitative method is useful for diagnosing CMT1A and HNPP.
